Anastasia N. Piniaeva

Author

Also Known As

A. N. Piniaeva, A.N. Piniaeva, Anastasia N Piniaeva, Anastasia N. Piniaeva, Anastasia Piniaeva, Anastasiia N. Piniaeva, E.K. Atremov, А. Н. Пиняева, А.Н. Пиняева

Publications

250

Citations

H-Index

Concepts

All Affiliations

Sechenov University Russian Academy of Sciences Chumakov Institute of Poliomyelitis and Viral Encephalitides Lomonosov Moscow State University Kirov State Medical Academy

About

Anastasia N. Piniaeva is an author at Sechenov University specializing in vaccine development, humoral immunity, and precision vaccinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	73
2	Allergy	1	1	73
3	Immunology	1	1	73
4	Humoral Immunity	1	1	73
5	Immunodominance	1	1	73

Anastasia N. Piniaeva

Publications

222

Citations

H-Index

Page 1

	Year	Citations
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies Liubov I. Kozlovskaya, Anastasia N. Piniaeva, G. M. Ignatyev, Emerging Microbes & Infections Vaccine ResearchImmunologyImmunodominanceImmunotherapeuticsVaccine Manufacturing Process	2021	73
Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak Liubov I. Kozlovskaya, Anastasia N. Piniaeva, G. M. Ignatyev, International Journal of Infectious Diseases	2020	51
Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence Nadezhda V. Yagovkina, K. A. Subbotina, Andrey A. Tsaan, Frontiers in Immunology	2022	38
Structural characterization of <scp>β‐propiolactone</scp> inactivated severe acute respiratory syndrome coronavirus 2 (<scp>SARS‐CoV</scp>‐2) particles Dmitry Bagrov, Andrey Moiseenko, Maria G. Karlova, Microscopy Research and Technique	2021	26
Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II Anastasia N. Piniaeva, G. M. Ignatyev, Liubov I. Kozlovskaya, Vaccines	2021	20
Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts Ilya Gordeychuk, Liubov I. Kozlovskaya, Nadezhda V. Yagovkina, Viruses	2023	14

Page 1